首页> 外文会议>Annual International Conference of the IEEE Engineering in Medicine and Biology Society >A Clinical Applicable Smartwatch Application for Measuring Hyperkinetic Movement Disorder Severity
【24h】

A Clinical Applicable Smartwatch Application for Measuring Hyperkinetic Movement Disorder Severity

机译:临床适用的SmartWatch应用,用于测量高基因运动障碍严重程度

获取原文

摘要

Measuring the severity of hyperkinetic movement disorders like tremor and myoclonus is challenging. Although many accelerometers are available to quantify movements, the vast majority lacks real-time analysis and an interface that makes it possible to real-time adjust therapy like deep brain stimulation (DBS). Here, we developed a smartwatch / smartphone application that is capable of real-time analysing movement disorder severity. Movement analysis was realised by integrating acceleration values, to velocity and subsequently to distance. Measured distances were compared with a validated accelerometer already applied for quantifying movement disorders. Further validation was done by quantitative assessment of simulated movement disorders in 10 healthy volunteers. Finally, the approach was tested in two patients treated with DBS to quantify the effect of different DBS settings on myoclonus and tremor severity, respectively. The distance measured with the application had a 96% accuracy. This was non-inferior (p = 0.76) compared to accelerometers already clinically applied. Furthermore, (simulated) movement disorder severity could be classified correctly in 93% of the cases. Finally, the method was capable of distinguishing effective from non-effective DBS parameters in two patients. In summary, with our approach we realised an instantaneous and reliable estimation of the severity of movement disorders which can assist in real time titrating therapy like DBS.
机译:测量像震颤和肌阵的超基因运动障碍的严重程度都具有挑战性。尽管许多加速度计可以量化运动,但绝大多数缺乏实时分析和一种使得可以实时调整治疗(DB)的实时调整治疗的界面。在这里,我们开发了一种能够实时分析运动障碍严重程度的SmartWatch /智能手机应用程序。通过将加速度值集成到速度并随后将运动分析实现。将测量的距离与已经施用于量化失调的验证的加速度计进行了比较。通过定量评估10个健康志愿者的模拟运动障碍进行进一步验证。最后,在用DBS处理的两名患者中测试了该方法,以分别定量不同DBS环境对肌阵挛和震颤严重程度的影响。使用申请测量的距离具有96%的精度。与已经在临床应用的加速度计相比,这是非较差的(p = 0.76)。此外,(模拟)运动障碍严重程度可以在93%的情况下正确进行分类。最后,该方法能够在两个患者中的非有效DBS参数中区分有效。总之,通过我们的方法,我们实现了对运动障碍严重程度的瞬间和可靠性估计,其可以有助于实时滴定滴定疗法等DBS。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号